Sunday, November 26, 2023
Home Tags COVAXIN

Tag: COVAXIN

For the study, 691 participants in the 18-45 age group were enrolled between June 2021 and January 2022 were enrolled.
COVID 19

Covishield Vs Covaxin: Which one is better against Covid variants? Here’s what study finds

Covaxin's Expanded Approval: Safeguarding Children Aged 6-12 Against COVID-19
COVID 19

Covaxin’s Expanded Approval: Safeguarding Children Aged 6-12 Against COVID-19

US FDA Pauses Covaxin Clinical Trials Following WHO Manufacturing Observations
COVID 19

US FDA Pauses Covaxin Clinical Trials Following WHO Manufacturing Observations

omicron
COVID 19

COVID-19 Vaccination In India: The Journey So Far  

Second dose of COVID-19 vaccine Covishield is currently given between 12-16 weeks.
COVID 19

COVID-19: NTAGI Reduces Gap Between Two Doses Of Covishield, Check Details

COVID 19

Covishield And Covaxin Get Regular Market Approval For Use In Adult Population

covaxin booster dose
COVID 19

Covaxin Booster Dose Neutralises Omicron Variant: All You Need To Know

123...21Page 1 of 21

Latest Post

About Healthwire


Formed by a group of committed health zealots, Healthwire Media Group is the fastest growing startup which explores myriad hues of health in every aspect of life.  Read More

Advertise with us

For Booking Advertisement, Contact: Shobha Mishra Email: shobha@healthwire.co Mob: +91 96670 41427  For any other queries write to us at : info@healthwire.co

Latest News

Categories

© Healthwire.co | All rights reserved